Vollara Air Purifiers Team Watts
4 members Health and Fitness
Aerus ActivePure Technology Announces SARS-CoV-2 Test Results Aerus ActivePure Air and Surface Purifier Provides 99.98% COVID-19 Surface Reduction Rate in Controlled, Independent Laboratory Studies DALLAS (September 30, 2020) , Aerus, the global leader in air and surface purification solutions, announced today that testing data conducted by independent FDA-compliant laboratory, MRIGlobal, established a 99.98% surface kill rate of live SARS-CoV-2 virus in just 7 hours with the Aerus Hydroxyl Blaster air and surface purifier. Data collected in the study showed a 93% surface kill in 3 hours and 98% surface kill in 6 hours of live SARS-CoV-2, even when covered by a protective biofilm, with the Aerus Hydroxyl Blaster and its patented ActivePure Technology. In addition, Aerus is running independent laboratory tests to demonstrate the efficacy of ActivePure Technology on airborne SARS-CoV-2 virus. These results will be submitted to the FDA for review and clearance. Aerus Technology has a 99.9999% kill rate of airborne RNA viruses in just 60 minutes and 99.999% in 30 minutes, as proven with the FDA 510(k) cleared Aerus Medical Guardian with ActivePure, and performs materially faster on airborne pathogens while it simultaneously destroys surface pathogens. The patented, photocatalyst ActivePure Technology in the Aerus Hydroxyl Blaster is the same ActivePure Technology used in the Aerus FDA Class II Medical Device, the Aerus Medical Guardian. Aerus is confident its upcoming SARS-CoV-2 RNA virus airborne tests will demonstrate strong performance both in speed and the reduction level of the SARS-CoV-2 virus in the air, based on the airborne test results with non-lipid surrogate, MS2 Bacteriophage RNA virus. The SARS-CoV-2 RNA virus is a lipid virus, which the FDA has acknowledged is easier to destroy than non-lipid viruses. Aerus is working expeditiously to confirm the airborne disinfection rate on the SARS-CoV-2 virus. When available, this data will be submitted to the FDA for clearance. Aerus is awaiting final approval from the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for the Aerus Hydroxyl Blaster with ActivePure Technology for use in reducing SARS-CoV-2 surface pathogens. The results have also been submitted by Aerus to the FDA-equivalent Canadian and European Union regulators, requesting that they clear Aerus ActivePure devices to combat the SARS-CoV-2 coronavirus. Aerus expects to receive clearances in all jurisdictions in the near future
Jan Watts
Bithi Apa
Jessica Riley Weaver
Saina432
INTERMITTENT FASTING
33 members Health and Fitness
Hello and welcome to my support group for Intermittent Fasting Lifestyle. Everyone is welcome here and encouraged to share info on IF as well as other types of fasts, including EF, ADF etc. the only exception is dry fasting info, (no food or liquids) which is NOT to be promoted here. I am a Plexus Supplement user and ambassador but will NOT be promoting those outside of general info for those who are using them with IF. Plexus is food, and therefore needs to be considered when doing clean IF. If you are using other supplementation, and need to question or want to share info on how to integrate those with your fasting plan, that is fine. No promos or selling of any supplements will be allowed here but you are certainly free to connect separately from this group of you have any questions. The main focus of this group is to have a support system for all of us choosing IF or other similar plans as a lifestyle! Welcome to our group!
Leeanna Porter
Alex Taylor
Ambra Workman
+30